New Zealand - English - Medsafe (Medicines Safety Authority)

johnson & johnson (new zealand) limited - alginic acid 15.5 mg/ml; aluminium hydroxide gel dried 20 mg/ml equivalent to 18.81 mg/ml al. hydroxide dried gel fine mesh (50% al. oxide); calcium carbonate 25 mg/ml (28.2mg including 12.8 % manufacturers overage.); magnesium hydroxide 20 mg/ml (added as magnesium hydroxide paste 30%); sodium bicarbonate 25 mg/ml - oral suspension - active: alginic acid 15.5 mg/ml aluminium hydroxide gel dried 20 mg/ml equivalent to 18.81 mg/ml al. hydroxide dried gel fine mesh (50% al. oxide) calcium carbonate 25 mg/ml (28.2mg including 12.8 % manufacturers overage.) magnesium hydroxide 20 mg/ml (added as magnesium hydroxide paste 30%) sodium bicarbonate 25 mg/ml excipient: butyl hydroxybenzoate imitation creme de menthe rf-137 wl-4649 propyl hydroxybenzoate purified water saccharin sodium sorbitol terpeneless lemon oil xanthan gum

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - aluminum hydroxide (unii: 5qb0t2iun0) (aluminum hydroxide - unii:5qb0t2iun0) - aluminum hydroxide 160 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - desvenlafaxine, quantity: 100 mg - tablet, modified release - excipient ingredients: alginic acid; citric acid monohydrate; povidone; microcrystalline cellulose; hypromellose; magnesium stearate; purified talc; titanium dioxide; macrogol 8000; iron oxide red; iron oxide black - for the treatment of major depressive disorder, including the preventiton of relapse. not indicated for paediatric use.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - desvenlafaxine, quantity: 50 mg - tablet, modified release - excipient ingredients: citric acid monohydrate; povidone; alginic acid; microcrystalline cellulose; magnesium stearate; purified talc; hypromellose; titanium dioxide; macrogol 6000; iron oxide red - for the treatment of major depressive disorder, including the preventiton of relapse. not indicated for paediatric use.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - desvenlafaxine, quantity: 100 mg - tablet, modified release - excipient ingredients: purified talc; povidone; magnesium stearate; alginic acid; citric acid monohydrate; microcrystalline cellulose; hypromellose; titanium dioxide; macrogol 8000; iron oxide red; iron oxide black - for the treatment of major depressive disorder, including the preventiton of relapse. not indicated for paediatric use.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - desvenlafaxine, quantity: 100 mg - tablet, modified release - excipient ingredients: povidone; hypromellose; alginic acid; citric acid monohydrate; microcrystalline cellulose; magnesium stearate; purified talc; titanium dioxide; macrogol 8000; iron oxide red; iron oxide black - for the treatment of major depressive disorder, including the preventiton of relapse. not indicated for paediatric use.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - desvenlafaxine, quantity: 50 mg - tablet, modified release - excipient ingredients: povidone; alginic acid; citric acid monohydrate; magnesium stearate; hypromellose; purified talc; microcrystalline cellulose; titanium dioxide; macrogol 6000; iron oxide red - for the treatment of major depressive disorder, including the preventiton of relapse. not indicated for paediatric use.

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - sodium bicarbonate, quantity: 234 mg; magaldrate, quantity: 371 mg; alginic acid, quantity: 215 mg - tablet, chewable - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; saccharin sodium; purified talc; magnesium stearate; mannitol; microcrystalline cellulose; flavour - fast, long lasting relief from the burning pain of heartburn, indigestion and gastric reflux.

Malta - English - Medicines Authority

bayer public limited company 400 south oak way, reading berkshire rg2 6ad, united kingdom - calcium carbonate, alginic acid, magnesium carbonate, heavy - chewable tablet - calcium carbonate 625 mg alginic acid 150 mg magnesium carbonate, heavy 73.5 mg - drugs for acid related disorders

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - folic acid, quantity: 500 microgram - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; calcium ascorbate dihydrate; sodium bicarbonate; magnesium stearate; alginic acid - maintain/support general health and wellbeing ; aid/assist healthy red blood cell production ; maintain/support (state vitamin/mineral) within normal range ; helps maintains/support healthy foetal cns/brain development ; help to prevent neural tube defects such as spina bifida and/or anencephaly